Treatment | Disease onset,DPI (range) | Disease incidence, n/n total (%) | Mean maximum score (range) | Cumulative disease score | Inflammatory area (%) | Demyelinated area (%) | Axonal loss (%) |
---|---|---|---|---|---|---|---|
Control | 9.0 ± 1.0 (7 to 10) | 12/12 (100) | 3.5 ± 0.5 (3 to 4) | 30.4 (±9.57) | 14.62 ± 6.6 | 0.68 ± 0.3†| 6.1 ± 2.0†|
BMSC | 10.9 ± 1.9 (8 to 13) | 10/10 (100) | 2.3 ± 1.1 (1 to 4) | 14.2 ± 11.8 | 7.3 ± 4.9 | 0.91 ± 0.3 | 1.5 ± 0.9 |
ASC | 9.7 ± 0.9 (9 to 15) | 9/12 (75) | 2.6 ± 0.7 (1 to 4) | 16.1 ± 7.2* | 5.1 ± 4.8 | 0.75 ± 0.2 | 1.3 ± 1.5 |
SVF | 9.3 ± 1.6 (2 to 3) | 10/12 (83) | 2.6 ± 0.7 (1 to 4) | 10.8 ± 6.4* | 6.7 ± 4.4 | 0.76 ± 0.2 | 3.1 ± 0.9 |